Table 4.
Author (year) | Sample size a (% of whole study) |
Cancer type/s Stage |
Treatment status at point of CT imaging | Timing of HRQOL assessments | HRQOL domain |
Coefficient Univariate analysis |
P value | Adjusted for confounders |
Coefficient Multivariate analysis |
P value |
---|---|---|---|---|---|---|---|---|---|---|
Aleixo et al. (2020) 39 | 99 (100) |
Breast Stages 0–III |
Pre‐chemotherapy Unclear surgical status |
Baseline only (pre‐chemotherapy) |
Global Physical function Social/family Emotional Functional |
Linear regression −0.12 −0.63 −0.27 −0.006 −0.19 |
0.052 0.002 0.16 0.98 0.18 |
Unadjusted | ||
Daly et al. (2020) 41 | 428 (41.7) |
Gastrointestinal Lung Other Stages III–IV Incurable |
81% receiving active palliative chemotherapy Unclear treatment and surgical status |
Baseline only (within 12 weeks of CT) |
Global Physical function Role Emotional Cognitive Social |
Spearman −0.052 −0.164 −0.070 −0.078 −0.026 −0.104 |
0.282 0.001 0.149 0.103 0.592 0.034 |
Unadjusted | ||
Derksen et al. (2020) 42 | 221 (100) |
Colorectal Stage IV Unresectable |
Post‐chemotherapy treatment Prior surgical resection in unspecified number of participants |
Baseline (enrolment) Every 9 weeks until PD1 |
Global Physical domain Role domain Emotional domain Cognitive Social |
Pearson 0.089 0.098 0.002 −0.006 0.091 0.035 |
0.19 0.15 0.97 0.02 0.18 0.61 |
Unadjusted b | ||
Gigic et al. (2020) 43 | 138 (100) |
Colorectal Stages I–IV Resectable |
Prior chemotherapy in 53 (38%) participants Pre‐surgery |
Pre‐surgery (baseline) 6 and 12 months post‐surgery |
Global Physical domain Role Social |
Spearman 0.03 0.19 0.07 −0.06 |
0.68 0.02 0.42 0.52 |
Age Gender Tumour stage Tumour site Neoadjuvant treatment Baseline HRQOL |
Linear regression −0.19 0.18 −0.27 0.12 |
0.50 0.44 0.47 0.72 |
Bye et al. (2017) 27 | 734 (100) |
Lung Stages IIIB–IV Incurable |
Pre‐chemotherapy Unclear surgical status |
Baseline only (pre‐chemotherapy) |
Global Males Females Physical domain Males Females Role domain Males Females |
Linear regression: flexible non‐linear modelling with restricted cubic splines |
0.001 0.15 0.016 0.004 0.02 0.012 |
Age Tumour stage |
Linear regression: flexible non‐linear modelling with restricted cubic splines |
All significant associations in univariate analysis remained significant (P < 0.05) Individual P values not reported |
Sample size: number of participants included in analysis of relationship between skeletal muscle mass and HRQOL.
Data in original study were adjusted for multiple cofounders; data supplied for this review are unadjusted.
HRQOL, health‐related quality of life; PD1, first progression of disease.